• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾嗜酸细胞瘤中线粒体复合物I缺乏。

Mitochondrial complex I is deficient in renal oncocytomas.

作者信息

Simonnet Helene, Demont Jocelyne, Pfeiffer Kathy, Guenaneche Leila, Bouvier Raymonde, Brandt Ulrich, Schagger Hermann, Godinot Catherine

机构信息

CGMC (Center of Molecular and Cell Genetics), Unit 5534 of the CNRS and the University Lyon 1 Claude Bernard, Villeurbanne, France.

出版信息

Carcinogenesis. 2003 Sep;24(9):1461-6. doi: 10.1093/carcin/bgg109. Epub 2003 Jul 4.

DOI:10.1093/carcin/bgg109
PMID:12844484
Abstract

Renal oncocytomas are benign tumors characterized by dense accumulation of mitochondria the cause of which remains unknown so far. Consistently, mitochondrial DNA content and the amounts and catalytic activities of several oxidative phosphorylation (OXPHOS) complexes were known to be increased in these tumors, but it was not ascertained that the OXPHOS system was functional. Here we investigated mitochondrial complex I and found that its NADH dehydrogenase activity and protein content were specifically decreased in oncocytomas, in stark contrast with the parallel decrease of all respiratory chain complexes in other, malignant, renal tumors. We conclude that deficiency of complex I in oncocytomas might be the early event causing the increased mitochondrial biogenesis, attempting to compensate for the loss of OXPHOS function. Since other tumors were found to be linked to mitochondrial deficiencies like genetic alterations of fumarate hydratase or succinate dehydrogenase, oncocytoma could be the third type of benign tumor associated with impairment of mitochondrial ATP production in an oxidative, quiescent tissue. Besides, complex I enzyme activity was moderately decreased in the vicinity of oncocytomas, when compared with normal tissue adjacent to other renal tumors. This suggested that oncocytomas are the result of at least two serial modifications altering the mitochondrial respiratory chain.

摘要

肾嗜酸细胞瘤是一种良性肿瘤,其特征是线粒体密集堆积,其原因至今仍不清楚。一直以来,已知这些肿瘤中线粒体DNA含量以及几种氧化磷酸化(OXPHOS)复合物的数量和催化活性会增加,但尚未确定OXPHOS系统是否具有功能。在此,我们研究了线粒体复合物I,发现其NADH脱氢酶活性和蛋白质含量在嗜酸细胞瘤中特异性降低,这与其他恶性肾肿瘤中所有呼吸链复合物的平行降低形成鲜明对比。我们得出结论,嗜酸细胞瘤中复合物I的缺陷可能是导致线粒体生物合成增加的早期事件,试图弥补OXPHOS功能的丧失。由于发现其他肿瘤与线粒体缺陷有关,如延胡索酸水合酶或琥珀酸脱氢酶的基因改变,嗜酸细胞瘤可能是第三种与氧化、静止组织中线粒体ATP产生受损相关的良性肿瘤。此外,与其他肾肿瘤相邻的正常组织相比,嗜酸细胞瘤附近的复合物I酶活性适度降低。这表明嗜酸细胞瘤是至少两个连续改变线粒体呼吸链的修饰的结果。

相似文献

1
Mitochondrial complex I is deficient in renal oncocytomas.肾嗜酸细胞瘤中线粒体复合物I缺乏。
Carcinogenesis. 2003 Sep;24(9):1461-6. doi: 10.1093/carcin/bgg109. Epub 2003 Jul 4.
2
Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.突变型线粒体DNA的克隆性扩增与良性肾嗜酸细胞瘤的肿瘤形成及复合体I缺陷相关。
Hum Mol Genet. 2008 Apr 1;17(7):986-95. doi: 10.1093/hmg/ddm371. Epub 2007 Dec 21.
3
Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.肾嗜酸细胞瘤中线粒体DNA突变导致复合体I缺失。
Clin Cancer Res. 2008 Apr 15;14(8):2270-5. doi: 10.1158/1078-0432.CCR-07-4131.
4
Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency.遗传性复合体I缺乏症中复合体I及其他线粒体氧化磷酸化复合体在组装或稳定性方面的差异。
Hum Mol Genet. 2004 Mar 15;13(6):659-67. doi: 10.1093/hmg/ddh071. Epub 2004 Jan 28.
5
Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.甲状腺嗜酸细胞癌中氧化磷酸化缺陷与影响复合体I和复合体III的致病性线粒体DNA突变有关。
Cancer Res. 2006 Jun 15;66(12):6087-96. doi: 10.1158/0008-5472.CAN-06-0171.
6
Human mitochondrial complex I deficiency: investigating transcriptional responses by microarray.人类线粒体复合体I缺乏症:通过微阵列研究转录反应。
Neuropediatrics. 2003 Feb;34(1):14-22. doi: 10.1055/s-2003-38618.
7
The oxidative phosphorylation (OXPHOS) system: nuclear genes and human genetic diseases.氧化磷酸化(OXPHOS)系统:核基因与人类遗传疾病
Bioessays. 2001 Jun;23(6):518-25. doi: 10.1002/bies.1071.
8
Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors.嗜酸性甲状腺肿瘤中线粒体ATP合成缺陷。
J Clin Endocrinol Metab. 2001 Oct;86(10):4920-5. doi: 10.1210/jcem.86.10.7894.
9
Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma.线粒体呼吸链含量低与肾细胞癌的肿瘤侵袭性相关。
Carcinogenesis. 2002 May;23(5):759-68. doi: 10.1093/carcin/23.5.759.
10
Mitochondria with tubulovesicular cristae in renal oncocytomas.肾嗜酸细胞瘤中具有管状囊状嵴的线粒体。
Ultrastruct Pathol. 2010 Dec;34(6):315-20. doi: 10.3109/01913123.2010.506021.

引用本文的文献

1
The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer.瓦伯格假说与癌症线粒体代谢理论的出现。
J Bioenerg Biomembr. 2025 Apr 8. doi: 10.1007/s10863-025-10059-w.
2
Energy Metabolism Behavior and Response to Microenvironmental Factors of the Experimental Cancer Cell Models Differ from that of Actual Human Tumors.实验性癌细胞模型的能量代谢行为及对微环境因素的反应与实际人类肿瘤不同。
Mini Rev Med Chem. 2025;25(4):319-339. doi: 10.2174/0113895575322436240924101642.
3
TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma.
TFE3融合蛋白指导一种致癌转录程序,该程序驱动氧化磷酸化并揭示易位性肾细胞癌的脆弱性。
bioRxiv. 2024 Aug 10:2024.08.09.607311. doi: 10.1101/2024.08.09.607311.
4
Targeting the Metabolic Paradigms in Cancer and Diabetes.针对癌症和糖尿病中的代谢模式
Biomedicines. 2024 Jan 17;12(1):211. doi: 10.3390/biomedicines12010211.
5
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer.代谢失调与癌症表观遗传学的相互作用
Biomolecules. 2023 Jun 5;13(6):944. doi: 10.3390/biom13060944.
6
Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma.使甲状腺滤泡细胞癌适应线粒体复合物 I 缺失的效应物。
Cancer Discov. 2023 Aug 4;13(8):1904-1921. doi: 10.1158/2159-8290.CD-22-0976.
7
Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells.线粒体氧化还原适应使 SDH 缺陷细胞能够进行替代的天冬氨酸合成。
Elife. 2023 Mar 8;12:e78654. doi: 10.7554/eLife.78654.
8
Mitochondrial Cristae Morphology Reflecting Metabolism, Superoxide Formation, Redox Homeostasis, and Pathology.线粒体嵴形态反映代谢、超氧化物形成、氧化还原稳态及病理学
Antioxid Redox Signal. 2023 Oct;39(10-12):635-683. doi: 10.1089/ars.2022.0173. Epub 2023 Apr 11.
9
Mitochondrial DNA is a major source of driver mutations in cancer.线粒体 DNA 是癌症驱动突变的主要来源。
Trends Cancer. 2022 Dec;8(12):1046-1059. doi: 10.1016/j.trecan.2022.08.001. Epub 2022 Aug 27.
10
Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.肾嗜酸细胞瘤:揭开肾癌“双重伪装”的诊断挑战。
Int J Mol Sci. 2022 Feb 26;23(5):2603. doi: 10.3390/ijms23052603.